Nutreco

ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.

BiomEdit is an innovation company focused on developing novel probiotics and microbiome-derived bioactives to enhance animal health. The company aims to tackle significant challenges in animal agriculture and food security by harnessing the potential of the microbiome. Utilizing a unique platform that incorporates high-throughput sequencing and data analytics, BiomEdit rapidly discovers and screens new probiotic species and bioactive molecules. These innovations can be engineered for improved thermostability, increased production of beneficial metabolites, and expression of immune-modulating proteins. By creating next-generation products that promote animal health without relying on antibiotics, BiomEdit addresses critical needs in livestock production and disease management.

Roslin Technologies is an ag-tech and food tech company focused on enhancing protein production through innovative biotechnologies. The company specializes in animal stem cell research, having developed perpetually self-renewing, pluripotent stem cells, which are pivotal for the advancement of cultivated meat products for consumers. Roslin's intellectual property and technological platforms are designed to supply these cell lines and related media formulations to the cultivated meat sector. Additionally, the company aims to leverage its stem cell technology to create cell therapies that address incurable diseases in animals, thereby supporting the meat industry in reducing costs and accelerating market entry.

Eruvaka Technologies Private Limited specializes in developing and selling on-farm diagnostic equipment tailored for aquaculture farmers. Founded in 2012 and based in Guntur, India, the company offers innovative solutions such as the Eruvaka Floating Buoy, which provides real-time measurements of essential water parameters vital for shrimp growth and survival. This equipment connects to a mobile application, allowing farmers to monitor pond conditions directly from their smartphones. By integrating sensors, mobile connectivity, and decision-making tools, Eruvaka aims to enhance aquaculture monitoring and automation, helping farmers reduce risks and production costs while increasing yield and sustainability.

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

Proteon Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with renal and vascular diseases. Founded in 2001 and based in Waltham, Massachusetts, the company is known for its lead product candidate, vonapanitase, which is designed to improve hemodialysis vascular access outcomes. Vonapanitase, a recombinant human elastase, has successfully completed Phase II and Phase III clinical trials for patients suffering from chronic kidney disease and is currently being evaluated in a Phase I clinical trial for peripheral artery disease. The company aims to leverage its understanding of tissue remodeling to create effective treatments that address significant medical needs in these patient populations.

Proteon Pharmaceuticals Ltd. is a company based in Lodz, Poland, focused on developing bacteriophage-based products aimed at enhancing animal and human health while promoting environmental sustainability. Established in 2005, Proteon leverages precision biology to create solutions that mitigate the reliance on antibiotics and address the challenges of antimicrobial resistance. The company offers a range of services, including high-throughput screening (HTS) and high-content screening (HCS) tests to identify new active substances with specific immunomodulatory properties. Additionally, Proteon provides contract services for pharmaceutical companies to explore various chemical libraries. Its product pipeline includes solutions designed to improve performance and food safety in poultry, as well as to prevent economically significant bacterial diseases in aquaculture and dairy farming.

Enough is a technology spin-out from the University of Strathclyde focused on the development and commercialization of innovative mycoprotein-based food products. The company aims to enhance the sustainability of protein production by integrating its manufacturing processes into existing bio-refinery operations that produce bio-ethanol and animal feed. This approach not only optimizes the production of food but also contributes to a circular economy by utilizing resources efficiently. Enough's products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions. The fermentation process employed is zero-waste, resulting in food ingredients that provide all essential amino acids and are high in dietary fiber, making them viable substitutes for meat at a low cost.

ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the production of cultured meat by utilizing tissue engineering techniques. Mosa Meat harvests adult stem cells from the muscle tissue of living cows, allowing it to grow meat without the need for animal slaughter. This innovative process enables the production of products such as hamburgers and aims to reduce the environmental impact associated with traditional meat production. By creating real meat from animal cells, Mosa Meat contributes to a more sustainable food system, significantly lowering emissions, water usage, and land requirements while minimizing animal suffering.

West Coast Salmon plans to build and operate an industrial scale.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the production of cultured meat by utilizing tissue engineering techniques. Mosa Meat harvests adult stem cells from the muscle tissue of living cows, allowing it to grow meat without the need for animal slaughter. This innovative process enables the production of products such as hamburgers and aims to reduce the environmental impact associated with traditional meat production. By creating real meat from animal cells, Mosa Meat contributes to a more sustainable food system, significantly lowering emissions, water usage, and land requirements while minimizing animal suffering.

BlueNalu, Inc. is a cellular aquaculture company based in San Diego, California, founded in 2017. It specializes in the production and marketing of cell-based seafood products, cultivating fish tissue from cells to meet the growing global demand for seafood while promoting sustainability. By utilizing innovative techniques, BlueNalu produces healthy, safe, and tasty seafood dishes that are free from plastics, pathogens, toxins, and other contaminants. The company aims to support ocean diversity and sustainability, providing consumers and restaurants with trusted seafood options that align with ethical and environmental standards.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the production of cultured meat by utilizing tissue engineering techniques. Mosa Meat harvests adult stem cells from the muscle tissue of living cows, allowing it to grow meat without the need for animal slaughter. This innovative process enables the production of products such as hamburgers and aims to reduce the environmental impact associated with traditional meat production. By creating real meat from animal cells, Mosa Meat contributes to a more sustainable food system, significantly lowering emissions, water usage, and land requirements while minimizing animal suffering.

ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.

Eruvaka Technologies Private Limited specializes in developing and selling on-farm diagnostic equipment tailored for aquaculture farmers. Founded in 2012 and based in Guntur, India, the company offers innovative solutions such as the Eruvaka Floating Buoy, which provides real-time measurements of essential water parameters vital for shrimp growth and survival. This equipment connects to a mobile application, allowing farmers to monitor pond conditions directly from their smartphones. By integrating sensors, mobile connectivity, and decision-making tools, Eruvaka aims to enhance aquaculture monitoring and automation, helping farmers reduce risks and production costs while increasing yield and sustainability.

Hi-Pro Feeds LP is a manufacturer and distributor of animal nutrition products, operating in Canada and the United States. Founded in 2012 and based in Okotoks, Canada, the company specializes in producing a wide range of feeds designed for various animal species, including dairy and beef cattle, poultry, swine, sheep, goats, and wildlife. Hi-Pro Feeds offers bulk feed, pre-mixes, dietary supplements, and commodity ingredients aimed at optimizing the health and nutrition of livestock. The company serves commercial producers through a network of dealers, ensuring that its products meet the needs of the agricultural sector. As of 2017, Hi-Pro Feeds operates as a subsidiary of Nutreco N.V.

Micronutrients is a farming company dedicated to producing nutritional products, specifically focusing on animal feed ingredients. Committed to scientific research, the company develops precision feed ingredients and trace minerals tailored for beef, dairy, poultry, and swine. Through its innovative offerings, Micronutrients aims to enhance animal productivity, immunity, and overall performance, providing cost-effective solutions for its customers in the agricultural sector.